Essex Woodlands Health Ventures

About The Fund

Essex Woodlands, now operating as EW Healthcare Partners, is a venture capital firm founded in 1985, with a dedicated focus on diversified healthcare investing. With nearly $2.5 billion under management, the firm is one of the largest and most established healthcare venture capital firms in the world. Essex Woodlands primarily serves as the lead investor in the founding or critical financings of healthcare companies, investing in fields such as pharmaceuticals, biotechnology, medical devices, services, and information technology. Their vast experience of over 300 years of collective healthcare experience among their team members positions them uniquely in the market. The firm has continuously demonstrated its expertise by working closely with highly-experienced management teams, aiming to build best-of-breed businesses in the healthcare industry. EW Healthcare Partners boasts a portfolio of companies that are engaged in a wide range of healthcare services, from developing the world's smallest and minimally invasive micro blood pump to specializing in oncology and critical care drugs. They partner with innovative companies such as Abiomed, Biotoscana, and EUSA Pharma, providing strategic guidance and supporting business plan execution, which is evidenced by the praise from CEOs and industry leaders. Essex Woodlands manages investments across four principal offices located in Palo Alto, Houston, New York, and London. They exercise investment amounts ranging from a minimum of $10 million to a maximum of $67 million, scaling investments according to the stage and requirements of the portfolio company. Over the years, Essex has expanded its reach from early-stage investments to include late-stage healthcare investments, such as mature venture, growth equity, and PIPE (Private Investment in Public Equity) investment opportunities, with a specialty in early-stage company investments.